0 Comentários
0 Compartilhamentos
287 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Precision Oncology Drug Portfolio Market Size, Industry Development and Forecast Insights"Executive Summary Precision Oncology Drug Portfolio Market Market: Share, Size & Strategic Insights The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast period This Precision Oncology Drug Portfolio Market Market research...0 Comentários 0 Compartilhamentos 322 Visualizações 0 Anterior
-
Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...0 Comentários 0 Compartilhamentos 197 Visualizações 0 Anterior
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Comentários 0 Compartilhamentos 837 Visualizações 0 Anterior
-
Antibody Drug Conjugates (ADCs) Market to Witness Accelerated Growth Amid Rising Oncology InnovationsThe Antibody Drug Conjugates (ADCs) Market has moved from niche oncology innovation to one of the most closely watched segments in biopharmaceutical development. Once considered technically complex and commercially uncertain, ADCs now represent a validated therapeutic platform with multiple regulatory approvals and an expanding clinical pipeline. In simple terms, ADCs combine the...0 Comentários 0 Compartilhamentos 346 Visualizações 0 Anterior
-
Generic Oncology Drug Market: What Manufacturing Quality Challenges Define the Generic Oncology Drug Supply Chain?The Generic Oncology Drug Market in 2026 faces significant manufacturing quality and supply chain resilience challenges that reflect the inherent complexity of producing potent cytotoxic oncology agents to the precise quality specifications required for patient safety and regulatory compliance across multiple global markets. The manufacture of generic chemotherapy agents requires highly...0 Comentários 0 Compartilhamentos 337 Visualizações 0 Anterior
-
How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...0 Comentários 0 Compartilhamentos 398 Visualizações 0 Anterior
-
Kirsten Rat Sarcoma (KRAS) Market: Targeted Therapies, Next-Generation Inhibitors (G12C), and Oncology Drug Development"Executive Summary Kirsten Rat Sarcoma (KRAS) Market Size and Share: Global Industry Snapshot Global Kirsten Rat Sarcoma (KRAS) market size was valued at USD 3.69 billion in 2024 and is projected to reach USD 3.37 billion by 2032, with a CAGR of 1.5% during the forecast period of 2025 to 2032. Kirsten Rat Sarcoma (KRAS) Market report offers the most appropriate solution for the...0 Comentários 0 Compartilhamentos 744 Visualizações 0 Anterior
-
Myxoid Round Cell Liposarcoma (MRCLS) Drug Market – Precision Oncology Therapies, Rare Cancer Research & Clinical Pipeline"Global Executive Summary Myxoid Round Cell Liposarcoma (MRCLS) Drug Market: Size, Share, and Forecast CAGR Value The Global Myxoid Round Cell Liposarcoma (MRCLS) Drug Market size was valued at USD 10.61 billion in 2024 and is expected to reach USD 14.3 billion by 2032, at a CAGR of 3.81% during the forecast period While preparing the first class Myxoid Round Cell Liposarcoma (MRCLS) Drug...0 Comentários 0 Compartilhamentos 447 Visualizações 0 Anterior
-
Osteosarcoma Market: Drug Development Pipeline, Chemotherapy and Targeted Therapy Analysis, and Orthopedic Oncology LandscapeExecutive Summary: The Global Osteosarcoma Treatment Market is a specialized sector within oncology, focused on the most common primary bone cancer, predominantly affecting children and young adults. The market is defined by a high unmet need, as the standard-of-care (chemotherapy and surgery) has seen limited survival improvements in decades. Growth is primarily fueled by the advancing...0 Comentários 0 Compartilhamentos 847 Visualizações 0 Anterior
-
Rhabdomyosarcoma Treatment Market: Drug Pipeline, Chemotherapy and Radiation Strategies, and Pediatric Oncology LandscapeThe Global Rhabdomyosarcoma (RMS) Treatment Market is a highly specialized segment within the global oncology and pediatric medicine industry. RMS is a rare but aggressive form of cancer that originates in mesenchyme cells, which normally develop into skeletal muscle. The market encompasses all therapeutic modalities, including chemotherapy, radiation therapy, surgery, and emerging targeted and...0 Comentários 0 Compartilhamentos 603 Visualizações 0 Anterior
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Comentários 0 Compartilhamentos 52 Visualizações 0 Anterior
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Comentários 0 Compartilhamentos 20 Visualizações 0 Anterior
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Comentários 0 Compartilhamentos 4 Visualizações 0 Anterior
-
High Potent Pharmaceuticals Product Market Analysis 2025–2031: CAGR Growth, Trends & Future OutlookHigh Potent Pharmaceutical Products are drugs that possess high therapeutic potency and can produce desired medical effects at very low concentrations. These products require strict regulatory compliance and safety protocols. They are widely used in advanced pharmaceutical research and specialized medical treatments. High Potent Pharmaceuticals Product Market Analysis and Industry...0 Comentários 0 Compartilhamentos 390 Visualizações 0 Anterior
-
How Are Treatments Advancing in Metastatic Solid Tumors Market?Executive Summary Metastatic Solid Tumors Market Size and Share: Global Industry Snapshot CAGR Value Data Bridge Market Research analyses a growth rate in the global metastatic solid tumors market in the forecast period 2022-2029. The Metastatic Solid Tumors report is an ultimate solution for businesses if they want to stay ahead of the competition in today's fast-moving business...0 Comentários 0 Compartilhamentos 30 Visualizações 0 Anterior
-
What Breakthrough Drug Delivery Technologies Are Fueling the Peptide-Drug Conjugate Therapeutics Market?Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...0 Comentários 0 Compartilhamentos 333 Visualizações 0 Anterior
Páginas Impulsionadas
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek